A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier BV in Osteoarthritis and Cartilage
- Vol. 10 (7), 506-517
- https://doi.org/10.1053/joca.2002.0798
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic resultsOsteoarthritis and Cartilage, 2002
- Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 updateArthritis & Rheumatism, 2000
- Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?Annals Of The Rheumatic Diseases, 1999
- Pharmacoeconomic Evaluation in the Real WorldPharmacoEconomics, 1999
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996
- Economic Evaluation of the Management of Pain in OsteoarthritisDrugs, 1996
- Guidelines for the medical management of osteoarthritisArthritis & Rheumatism, 1995
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Explanatory and pragmatic attitudes in therapeutical trialsJournal of Chronic Diseases, 1967
- Osteo-arthrosis and Disk Degeneration in an Urban PopulationAnnals Of The Rheumatic Diseases, 1958